A. B. Boz Er And İ. Er, "Targeting ITGβ3 to Overcome Trastuzumab Resistance in HER2-Positive Breast Cancer: Insights into TGF-β Signaling and Migration," x. International Congress of Molecular Medicine , İzmir, Turkey, pp.59, 2024
Boz Er, A. B. And Er, İ. 2024. Targeting ITGβ3 to Overcome Trastuzumab Resistance in HER2-Positive Breast Cancer: Insights into TGF-β Signaling and Migration. x. International Congress of Molecular Medicine , (İzmir, Turkey), 59.
Boz Er, A. B., & Er, İ., (2024). Targeting ITGβ3 to Overcome Trastuzumab Resistance in HER2-Positive Breast Cancer: Insights into TGF-β Signaling and Migration . x. International Congress of Molecular Medicine (pp.59). İzmir, Turkey
Boz Er, ASİYE, And İdris Er. "Targeting ITGβ3 to Overcome Trastuzumab Resistance in HER2-Positive Breast Cancer: Insights into TGF-β Signaling and Migration," x. International Congress of Molecular Medicine, İzmir, Turkey, 2024
Boz Er, ASİYE B. And Er, İdris. "Targeting ITGβ3 to Overcome Trastuzumab Resistance in HER2-Positive Breast Cancer: Insights into TGF-β Signaling and Migration." x. International Congress of Molecular Medicine , İzmir, Turkey, pp.59, 2024
Boz Er, A. B. And Er, İ. (2024) . "Targeting ITGβ3 to Overcome Trastuzumab Resistance in HER2-Positive Breast Cancer: Insights into TGF-β Signaling and Migration." x. International Congress of Molecular Medicine , İzmir, Turkey, p.59.
@conferencepaper{conferencepaper, author={ASİYE BÜŞRA BOZ ER And author={İdris Er}, title={Targeting ITGβ3 to Overcome Trastuzumab Resistance in HER2-Positive Breast Cancer: Insights into TGF-β Signaling and Migration}, congress name={x. International Congress of Molecular Medicine}, city={İzmir}, country={Turkey}, year={2024}, pages={59} }